Coordinated Assessment of Notifications of Trials Containing Overt Published Errors

Sponsor
Imperial College London (Other)
Overall Status
Unknown status
CT.gov ID
NCT01901523
Collaborator
(none)
15
1
1
18
0.8

Study Details

Study Description

Brief Summary

Clinical research, like all science, is self-correcting, with errors detected by the scientific community and communicated to the publishing journals, which then relay the information (and its resolution) to its readers. If this relaying process fails, science grinds to a halt. In this study we are testing its integrity.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Reporting of discrepancy to journal
N/A

Detailed Description

This prospective study documents the outcome of notification to journal editorial boards (or equivalent authorities) of factually incorrect or inconsistent claims, in reports they have published.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Phase II Study of Response of Medical Journal Editorial Boards to Notification of Serious Discrepancies in Published Clinical Trials in Human Patients.
Study Start Date :
Jun 1, 2014
Anticipated Primary Completion Date :
Aug 1, 2015
Anticipated Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Provision of information

Reporting of discrepancy to journal

Behavioral: Reporting of discrepancy to journal
Other Names:
  • Mathematical impossibility
  • Factual impossibility
  • Contradiction
  • Arithmetical impossibility
  • Error
  • Discrepancies
  • Fractional patients
  • Impossible percentage
  • Contradictory data
  • Negative standard deviation
  • Negative NYHA
  • Outcome Measures

    Primary Outcome Measures

    1. Time to correction, retraction, or other notification to the readership of discrepancy [12 months]

    Secondary Outcome Measures

    1. Time to initial response from journal [0-4 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Report of a clinical trial in humans of treatment of heart disease with bone marrow derived stem cells

    • Report containing discrepancy by reference to same report or another report

    Exclusion Criteria:
    • Discrepancy has already been corrected by an erratum

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 International Centre for Circulatory Health London United Kingdom W2 1LA

    Sponsors and Collaborators

    • Imperial College London

    Investigators

    • Study Chair: Darrel P Francis, MA MD FRCP, Imperial College London

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Darrel Francis, Professor of Cardiology, Imperial College London
    ClinicalTrials.gov Identifier:
    NCT01901523
    Other Study ID Numbers:
    • ICCH/13/SFI/Str
    First Posted:
    Jul 17, 2013
    Last Update Posted:
    May 19, 2014
    Last Verified:
    May 1, 2014
    Keywords provided by Darrel Francis, Professor of Cardiology, Imperial College London
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 19, 2014